Prognostic value of rare IKZF1 deletion in childhood B-cell precursor acute lymphoblastic leukemia: an international collaborative study. (Q41556401)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26202931%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

title

Prognostic value of rare IKZF1 deletion in childhood B-cell precursor acute lymphoblastic leukemia: an international collaborative study (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26202931%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

1 reference

lymphoblastic leukemia

1 reference

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26202931%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

Tomasz Szczepański

17

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26202931%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

Rosemary Sutton

21

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26202931%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

author name string

J M Boer

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26202931%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

A van der Veer

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26202931%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

D Rizopoulos

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26202931%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

M Fiocco

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26202931%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

E Sonneveld

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26202931%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

H A de Groot-Kruseman

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26202931%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

R P Kuiper

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26202931%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

P Hoogerbrugge

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26202931%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

M Horstmann

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26202931%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

M Zaliova

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26202931%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

C Palmi

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26202931%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

J Trka

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26202931%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

E Fronkova

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26202931%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

M do Socorro Pombo-de-Oliveira

15

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26202931%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

K Nebral

18

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26202931%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

A Attarbaschi

19

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26202931%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

N Venn

20

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26202931%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

C J Schwab

22

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26202931%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

A Enshaei

23

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26202931%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

A Vora

24

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26202931%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

M Stanulla

25

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26202931%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

M Schrappe

26

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26202931%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

G Cazzaniga

27

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26202931%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

V Conter

28

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26202931%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

M Zimmermann

29

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26202931%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

A V Moorman

30

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26202931%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

R Pieters

31

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26202931%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

M L den Boer

32

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26202931%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

W Mlynarski

16

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26202931%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

publication date

23 July 2015

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26202931%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26202931%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

volume

30

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26202931%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26202931%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

page(s)

32-38

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26202931%20AND%20SRC:MED&resulttype=core&format=json

Treatment of acute lymphoblastic leukemia

20 February 2020

cites work

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2015.199

Long-term results of five consecutive trials in childhood acute lymphoblastic leukemia performed by the ALL-BFM study group from 1981 to 2000.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2015.199

Integrated use of minimal residual disease classification and IKZF1 alteration status accurately predicts 79% of relapses in pediatric acute lymphoblastic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2015.199

Independent prognostic value of BCR-ABL1-like signature and IKZF1 deletion, but not high CRLF2 expression, in children with B-cell precursor ALL.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2015.199

Deletion of IKZF1 and prognosis in acute lymphoblastic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2015.199

IKZF1 deletions predict relapse in uniformly treated pediatric precursor B-ALL.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2015.199

IKZF1 deletion is an independent predictor of outcome in pediatric acute lymphoblastic leukemia treated according to the ALL-BFM 2000 protocol

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2015.199

IKZF1 deletions predict a poor prognosis in children with B-cell progenitor acute lymphoblastic leukemia: a multicenter analysis in Taiwan

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2015.199

Ikaros (IKZF1) alterations and minimal residual disease at day 15 assessed by flow cytometry predict prognosis of childhood BCR/ABL-negative acute lymphoblastic leukemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2015.199

A complex network of regulatory elements in Ikaros and their activity during hemo-lymphopoiesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2015.199

The Ikaros gene is required for the development of all lymphoid lineages

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2015.199

Transcriptional regulation of the Ikzf1 locus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2015.199

Ikaros fingers on lymphocyte differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2015.199

Genome-wide identification of Ikaros targets elucidates its contribution to mouse B-cell lineage specification and pre-B-cell differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2015.199

Selective regulation of lymphopoiesis and leukemogenesis by individual zinc fingers of Ikaros

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2015.199

Direct protein interactions are responsible for Ikaros-GATA and Ikaros-Cdk9 cooperativeness in hematopoietic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2015.199

High frequency of IKZF1 genetic alterations in adult patients with B-cell acute lymphoblastic leukemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2015.199

IKZF1 status as a prognostic feature in BCR-ABL1-positive childhood ALL.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2015.199

What is the relevance of Ikaros gene deletions as a prognostic marker in pediatric Philadelphia-negative B-cell precursor acute lymphoblastic leukemia?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2015.199

Expression of dominant-negative and mutant isoforms of the antileukemic transcription factor Ikaros in infant acute lymphoblastic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2015.199

Non-DNA-binding Ikaros isoform gene expressed in adult B-precursor acute lymphoblastic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2015.199

BCR-ABL1 induces aberrant splicing of IKAROS and lineage infidelity in pre-B lymphoblastic leukemia cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2015.199

Biclonal and biallelic deletions occur in 20% of B-ALL cases with IKZF1 mutations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2015.199

Breakpoint-specific multiplex polymerase chain reaction allows the detection of IKZF1 intragenic deletions and minimal residual disease monitoring in B-cell precursor acute lymphoblastic leukemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2015.199

Impact of IKZF1 deletions on IKZF1 expression and outcome in Philadelphia chromosome negative childhood BCP-ALL. Reply to "incidence and biological significance of IKZF1/Ikaros gene deletions in pediatric Philadelphia chromosome negative and Philade

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2015.199

Newly diagnosed acute lymphoblastic leukemia in China (II): prognosis related to genetic abnormalities in a series of 1091 cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2015.199

Stage-specific control of early B cell development by the transcription factor Ikaros

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2015.199

Loss of Ikaros DNA-binding function confers integrin-dependent survival on pre-B cells and progression to acute lymphoblastic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2015.199

Long-term follow-up of ETV6-RUNX1 ALL reveals that NCI risk, rather than secondary genetic abnormalities, is the key risk factor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2015.199

An intragenic ERG deletion is a marker of an oncogenic subtype of B-cell precursor acute lymphoblastic leukemia with a favorable outcome despite frequent IKZF1 deletions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2015.199

ERG deletion is associated with CD2 and attenuates the negative impact of IKZF1 deletion in childhood acute lymphoblastic leukemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2015.199

Cutting edge: predominant expression of a novel Ikaros isoform in normal human hemopoiesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2015.199

Identification and molecular characterization of recurrent genomic deletions on 7p12 in the IKZF1 gene in a large cohort of BCR-ABL1-positive acute lymphoblastic leukemia patients: on behalf of Gruppo Italiano Malattie Ematologiche dell'Adulto Acute

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2015.199

RAG-mediated recombination is the predominant driver of oncogenic rearrangement in ETV6-RUNX1 acute lymphoblastic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2015.199

High-risk childhood acute lymphoblastic leukemia in first remission treated with novel intensive chemotherapy and allogeneic transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2015.199

Evaluation of the long-term reconstituting subset of hematopoietic stem cells with CD150

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2015.199

BCR–ABL1 lymphoblastic leukaemia is characterized by the deletion of Ikaros

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2015.199

IKAROS isoform 6 enhances BCR-ABL1-mediated proliferation of human CD34+ hematopoietic cells on stromal cells.

21 January 2018

1 reference

12 December 2020

Cooperative genetic changes in pediatric B-cell precursor acute lymphoblastic leukemia with deletions or mutations ofIKZF1

1 reference

12 December 2020

Zinc finger-mediated protein interactions modulate Ikaros activity, a molecular control of lymphocyte development

1 reference

12 December 2020

The clinical impact of IKZF1 deletions in paediatric B-cell precursor acute lymphoblastic leukaemia is independent of minimal residual disease stratification in Nordic Society for Paediatric Haematology and Oncology treatment protocols used between 1

1 reference

12 December 2020

Self-renewal of the long-term reconstituting subset of hematopoietic stem cells is regulated by Ikaros.

1 reference

12 December 2020

IKZF1 deletion is an independent prognostic marker in childhood B-cell precursor acute lymphoblastic leukemia, and distinguishes patients benefiting from pulses during maintenance therapy: results of the EORTC Children's Leukemia Group study 58951.

1 reference

12 December 2020